Palei, A. C. T.; Sandrim, V. C.; Amaral, L. M.; Machado, J. S. R.; Cavalli, Ricardo de Carvalho; Lacchini, Riccardo 
; Duarte, Geraldo; Tanus-Santos, José Eduardo
Source: The Pharmacogenomics Journal. Unidade: FMRP
Subjects: POLIMORFISMO, HIPERTENSÃO NA GRAVIDEZ (TERAPIA), PRÉ-ECLÂMPSIA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALEI, A. C. T. et al. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 3, n. 3, 2011Tradução . . Disponível em: https://doi.org/10.1038/tpj.2011.31. Acesso em: 01 nov. 2024.APA
Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Cavalli, R. de C., Lacchini, R., et al. (2011). Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 3( 3). doi:10.1038/tpj.2011.31NLM
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Tanus-Santos JE. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/tpj.2011.31Vancouver
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Tanus-Santos JE. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/tpj.2011.31
